Squarepoint
NERV icon

Squarepoint’s Minerva Neurosciences NERV Stock Holding History

Squarepoint’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,947
Closed -$36K – 3249
2021
Q2 		$36K Buy
+1,947
New +$41.9K ﹤0.01% 3126
2021
Q1 		– Sell
-3,552
Closed -$66K – 3449
2020
Q4 		$66K Buy
+3,552
New +$89.5K ﹤0.01% 2775
2020
Q3 		– Sell
-2,874
Closed -$83K – 2720
2020
Q2 		$83K Buy
2,874
+55
+2% +$3.23K ﹤0.01% 2041
2020
Q1 		$136K Sell
2,819
-19,528
-87% -$1.18M ﹤0.01% 1581
2019
Q4 		$1.27M Buy
22,347
+16,394
+275% +$723K 0.01% 1190
2019
Q3 		$369K Sell
5,953
-7,068
-54% -$400K ﹤0.01% 1781
2019
Q2 		$586K Sell
13,021
-3,005
-19% -$150K 0.01% 1570
2019
Q1 		$1.01M Buy
16,026
+3,674
+30% +$221K 0.01% 1106
2018
Q4 		$666K Buy
12,352
+4,797
+63% +$351K 0.01% 1097
2018
Q3 		$759K Buy
7,555
+2,967
+65% +$223K 0.01% 1116
2018
Q2 		$303K Buy
4,588
+688
+18% +$41.8K ﹤0.01% 1370
2018
Q1 		$195K Buy
3,900
+728
+23% +$35K ﹤0.01% 1500
2017
Q4 		$154K Buy
+3,172
New +$157K ﹤0.01% 1869
2017
Q1 		– Sell
-1,296
Closed -$122K – 1789
2016
Q4 		$122K Buy
+1,296
New +$132K 0.01% 1587

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint's NERV Position: Q3 2021 in Review

Squarepoint sold out of Minerva Neurosciences (NERV) in Q3 2021, closing a stake of 1,947 shares — an estimated $36K sold.

Squarepoint first reported a position in NERV in Q4 2016 and held it in 14 quarters. The position peaked at $1.27M in Q4 2019. 46 funds tracked by Wall St. Rank hold NERV as of Q3 2021.

  • Squarepoint reported no remaining Minerva Neurosciences position as of Q3 2021 after selling out during the quarter.
  • Squarepoint sold 1,947 Minerva Neurosciences shares in Q3 2021, an estimated $36K.
  • Squarepoint first reported a position in Minerva Neurosciences in Q4 2016 and held it in 14 quarters.
  • Squarepoint's Minerva Neurosciences position peaked at $1.27M in Q4 2019.
  • 46 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2021.

Based on Squarepoint's 13F filing for Q3 2021, filed 15 Nov 2021.